RecruitingNot Applicable

Multicenter Registry of Patients With Subarachnoid Hemorrhage

Netherlands1,000 participantsStarted 2024-02-12

Plain-language summary

The purpose of this registry is to collect detailed information on the characteristics, treatment, and outcomes of patients with a subarachnoid hemorrhage. This information will enable research aimed at improving the safety and effectiveness of current and future treatments. By studying these data, the investigators aim to identify which treatment strategies offer the best results and which factors are most important in the care of patients with a subarachnoid hemorrhage. The knowledge gained from this research will help improve patient care in the future.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age ≥ 18 years * Spontaneous subarachnoid hemorrhage with blood in the basal cisterns and/or major fissures on non-contrast head computed tomography (CT), or xanthochromia of cerebrospinal fluid confirmed by spectrophotometric analysis. * Eligible etiologies/patterns: * Aneurysmal SAH * SAH from other intracranial vascular malformation (e.g. AVM, dural AVF) * Perimesencephalic SAH * Non-perimesencephalic angiogram negative SAH * SAH from intracranial artery dissection Exclusion Criteria: * Traumatic, neoplastic, infection related (except mycotic aneurysms), or iatrogenic SAH * Isolated convexity SAH

What they're measuring

Modified Rankin Scale (mRS)

Timeframe: 6 months ± 30 days after SAH

Trial details

NCT IDNCT07482124

SponsorUMC Utrecht

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-08-01

Contact for this trial

P.B. van Wijngaarden, MD

+88 755 5555 measure@umcutrecht.nl

View on ClinicalTrials.gov More Subarachnoid Hemorrhage, Spontaneous trials